EOG Resources Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? EOG Resources Inc trades at $154.2 (market cap $80.34B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: EOG Resources Inc is far larger — about 9.5× Hinge Health Inc. Class A Common Stock's market cap, and EOG Resources Inc pays a 2.66% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EOG | HNGE | |
|---|---|---|
Market Cap | $80.34B | $8.48B |
Volume | 2,309,813 | 879,799 |
Sector | Energy | Health |
52-Week High | $154.19 | $105.14 |
52-Week Low | $101.78 | $31.17 |
Typical Hold Time | 59 Days | 0 Days |
Enterprise Value | $83.69B | $8.10B |
Dividend Yield | 2.66% | — |
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $154.19, up 2.45% today, with a bullish technical outlook and strong fundamentals. The stock has beaten earnings estimates in recent quarters, with Q2 2026 EPS of $5.07 exceeding expectations. Valuation ratios are attractive, including a P/E of 11.92 and EV/EBITDA of 6.02. Recent news highlights robust operational execution and a CFO transition.
The outlook remains positive, supported by analyst consensus of a $165 price target and 59% buy ratings. Key risks include oil price volatility and capital expenditure trends. Upside potential hinges on sustained earnings growth and disciplined capital allocation amid energy market fluctuations.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →